#COVID-19

  • Robust China-CEEC partnership sets example of transregional cooperation

    Amid the ravaging COVID-19 pandemic and a reeling global economy, trade and economic ties between China and Central and Eastern European countries (CEECs) have demonstrated an unusually strong resilience, setting an example of transregional practical cooperation for the deeply challenged world community.

    Fresh data from China's Ministry of Commerce showed that in 2020, China's total trade volume with the 17 CEECs hit 103.45 billion U.S. dollars, registering an 8.4-percent spike, and crossing the 100-billion-dollar mark for the first time.

  • Rocket debris 'common, likely to fall in intl waters' despite Western hyping of 'China space threat'

    Debris from China's Long March-5B Y2 carrier rocket, which sent the first section of China's space station into orbit, is very likely to fall in international waters and people needn't worry, Chinese space analysts told the Global Times on Wednesday.

    Wreckage from rocket launches falling back to Earth is common in the aerospace field, and the Pentagon's reported claim that the rocket wreckage will fly back "out of control" and "may cause damage if it hits inhabited areas" is nothing but Western hype of the "China threat" in space technology advancement, observers noted.

  • Russia records 16,474 COVID-19 cases in past 24 hours

    Russia registered 16,474 COVID-19 cases over the past 24 hours, down from 16,643 the day before, taking the tally to 3,901,204, the coronavirus response center said on Wednesday.

    "Over the past day, 16,474 coronavirus cases were confirmed across 85 regions, including 1,748 cases (10.6 percent) that were detected actively, with people showing no clinical symptoms,"

  • Russia's Sputnik V COVID-19 vaccine 91.6 per cent effective: Lancet

    Russian's Sputnik V is 91.6 per cent effective at protecting people from COVID-19, according to the result of an interim analysis of the phase 3 trials published by the journal Lancet on Tuesday.

     "In the interim efficacy analysis of the randomized, double-blind, placebo-controlled clinical trial, where data on 19,866 volunteers were included in the efficacy analysis (14,964 of whom received the vaccine and 4,902 the placebo),

  • Scholar explains why China deeply misunderstood: media

    Far too many China "experts" have put focus on changing the country instead of understanding how it works and why it succeeds, said David Dodwell, executive director of the Hong Kong-APEC Trade Policy Study Group.

    HONG KONG, June 30 (Xinhua) -- The reason why China has been deeply misunderstood by some observers is that they have tried to change the country rather than to truly know it, espe

  • Scientists provide more strategic approach to COVID-19 testing

    A new study led by the US Geological Survey outlines a means to better estimate COVID-19 occurrence and trends in populations.

    Currently, COVID-19 testing is primarily limited to self-selected individuals, many of whom are symptomatic or have had contact with someone who is symptomatic. While these tests are useful for individual medical treatment and contact tracing, they do not provide health officials with a complete picture of the disease across the population.

  • Scottish government proposes urgent changes to the immigration system to tackle labour shortages

    The consequences of the UK Government’s decision to press ahead with Brexit despite the COVID-19 pandemic are to be debated in the Scottish Parliament.

  • Senior Chinese diplomat holds phone conversation with U.S. secretary of state

    Yang Jiechi, a member of the Political Bureau of the Communist Party of China (CPC) Central Committee and director of the Office of the Foreign Affairs Commission of the CPC Central Committee, on Friday held a phone conversation with U.S. Secretary of State Antony Blinken at the latter's request.

    Noting that dialogue and cooperation should be the mainstay of China-U.S. relations, Yang said cooperation must be mutually beneficial and address each other's concerns in a balanced manner.

  • Senior WHO officials congratulate China for COVID-19 control, yet no room for complacency

    Michael Ryan, executive director of the WHO's Health Emergencies Program, attributed China's success to a "huge partnership between communities, scientific institutions, public health institutions in the government" and "a lot of cooperation, very sustained commitment to getting the job done."

    Senior World Health Organization (WHO) officials on Monday congratulated the front-line health workers and the people in China for having reached a successful outcome in fighting COVID-19.

  • Six cities touch 80% threshold for herd immunity

    As China accelerates its vaccination pace, the Global Times found that six cities - Beijing, four cities in South China's Hainan Province, and Dalian in Northeast China's Liaoning Province - have a first-dose coverage rate above 80 percent, touching the threshold for herd immunity. In Southwest China's Yunnan Province, 25 land border ports have also achieved the goal.

    Fresh data for Shanghai, and some major cities in South China's Guangdong and Central China's Hubei provinces, show first-dose vaccination rates close to or exceeding 70 percent. They are soon to reach herd immunity when people get their second doses as scheduled, observers said on Wednesday.

  • Socialism with Chinese characteristics suits China’s national conditions the best: former Hungarian PM Peter Medgyessy

    The leadership of the Communist Party of China (CPC) and the social system of socialism with Chinese characteristics suit China the best and are bound to help China continue with development and achieve greater progress in the future, former Hungarian Prime Minister Peter Medgyessy said in an interview with People’s Daily recently.

    Every country is looking for a social system that best fits its history, culture and fundamental realities, Medgyessy said.

  • Study evaluates reason behind increased transmission in SARS-CoV-2 variants

    Recently a Johns Hopkins School of Medicine study found that although two SARS-CoV-2 variants are associated with the higher transmission, patients with these variants show no evidence of higher viral loads in their upper respiratory tracts compared to the control group.

    The emergence and higher transmission of the evolving variants of SARS-CoV-2, the virus that causes COVID-19, has been concerning.

  • Study finds lung function unaffected post COVID-19 infection

    COVID-19 infection does not appear to affect the lung function of young adults, according to a recent study by clinical researchers.

    These findings were recently presented at the virtual European Respiratory Society International Congress.

  • Study identifies how COVID-19 linked to Alzheimer's disease-like cognitive impairment

    A new Cleveland clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer's disease-like dementia.

    The findings, published in Alzheimer's Research and Therapy, indicate an overlap between COVID-19 and brain changes common in Alzheimer's and may help inform risk management and therapeutic strategies for COVID-19-associated cognitive impairment.

  • Study identifies potential factor contributing to severity of COVID-19

    A protein that may critically contribute to severe forms of COVID-19 has recently been identified by the University of Kent's School of Biosciences and the Institute of Medical Virology at Goethe-University.

  • Study proposes a low cost, high efficiency mask design

    A new paper in Oxford Open Materials Science, published by Oxford University Press, presents low-cost modifications to existing N95 masks that prolongs their effectiveness and improves their reusability post disinfectants.

  • Study sheds light on inequities in COVID-19 mortality across racial groups

    Black women are dying at significantly higher rates than white men, and that disparity in mortality rates among women of all races are greater than those between white women and white men. These are the findings of a new study led by Harvard University researchers.

    The results of the new research were published in the Journal of General Internal Medicine.

  • Study shows downside of not receiving second shot of COVID-19 vaccine

    A new study has shown that two months after the second Pfizer/Moderna vaccination, antibody response decreases 20 percent in adults with prior cases of COVID-19. The study also tested how well current vaccines resist emerging variants.

  • Study shows past COVID-19 infection does not fully protect people against re-infection

    Results of a new study led by researchers of The Mount Sinai School of Medicine suggest vaccination against COVID-19 remains crucial even in young adults who were previously infected.

    Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research Center.

  • Study shows why second dose of COVID-19 vaccine should not be skipped

    The second dose of a COVID-19 vaccine induces a powerful boost to a part of the immune system that provides broad antiviral protection, according to a study led by investigators at the Stanford University School of Medicine.

    The findings published in the journal Nature strongly supports the view that the second shot should not be skipped.

Partners